Downloads - Abzena

Filter by year

Filter by topic

MHC Associated Peptide Proteomics

Case Study MAPPs for Vaccine Design To identify MHC class I presented antigens derived from influenza strain H1N1, two sets of human epithelial cells are cultured, one is transfected with H1N1 antigen.

Manufacturing Capabilities Brochure

From Cell Line Development to Commercial Manufacturing

World ADC Presentation 2017

Abzena’s presentation at World ADC 2017 given by Campbell Bunce – Senior Vice President Technical Operations.

Annual Report 2017

Abzena PLC’s Annual Report 2017

Abzena Annual Report 2016

The Company’s Annual Report for the year ended 31 March 2016 was released on 15 June 2016

Corporate Fact Sheet

Abzena’s corporate fact sheet

Composite Proteins™ Fact Sheet

More information on Abzena’s Composite Protein™ technology. Protein Deimmunisation Technical Flyer

Optimisation of Pharmacokinetics Fact Sheet

Information on a our PEGylation technologies, including a TheraPEG case study on the PEGylation of interferon (IFN) a-2b

Composite Human Antibodies™ Fact Sheet

More information on our antibody humanisation and deimmunisation technology, including a case study on the deimmunisation of an anti-CTLA-4 antibody. Download the technical flyer : Composite-Human-Antibodies-Technical-Flyer.pdf

EpiScreen™ Epitope Mapping Fact Sheet

Further information on Abzena’s accurate and sensitive ex vivo T cell epitope identification technology including example results.

Interested in our services? Get In Touch